Abstract
To evaluate the diagnostic performance of the LI-RADS treatment response algorithm in hepatocellular carcinoma (HCC) patients treated with radioembolization (Y-90)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have